UPDATED: Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies Discovery Stage Partnering Terms and Agreements

UPDATED: Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Provides comprehensive understanding and unprecedented access to the pre-clinical stage partnering agreements entered into by the worlds leading biopharma companies Pre-clinical Stage Partnering Terms and Agreements

UPDATED: Option & Evaluation Agreements in Pharma and Biotech

Providing detailed understanding and analysis of how and why companies enter option and evaluation deals, plus access to actual option and evaluation agreements Option & Evaluation Agreements report

NEW: Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd edition

provides detailed understanding and analysis of how and why companies enter royalty financing deals Royalty financing report

NEW: Clinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2nd edition

Provides comprehensive understanding and unprecedented access to the clinical stage partnering agreements entered into by the worlds leading biopharma companies Clinical Stage Partnering report

UPDATED: Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 3rd edition

Providing detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals, plus access to actual agreements Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics

UPDATED: Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 3rd edition

Providing detailed understanding and analysis of how and why companies enter M&A deals, plus access to actual M&A agreements Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics

NEW: Partnering Agreements with Bigpharma

Partnering Agreements with Bigpharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies purchase now

In the news: Partnering continues to gain momentum in the summer of 2010

Recent deals include:

• Aspen nabs Sigma's drug business for $804m
• ISCT works with industry to launch cell therapy partnership
• Emergent buys Trubion for up to $135m
• Shire sells ADHD patch to Noven Pharma
• PregLem SA announces in-licensing deal with Merck Serono
• Teva completes acquisition of Ratiopharm

more news

GenericsWeb: 6 Fundamental Steps To Follow When Searching Patent Information

With potentially millions of dollars and many months of development time riding on accurate awareness of the patent landscape, one of the most common questions we ask is 'how can we minimise the risk of missing patents?' View the GenericsWeb article here

Best Partnering Practices - Just Common Sense, Part 4

The 4th and last part is about how business opportunities arise and develop, and how the design of partnering processes must reflect the peculiarities of this mechanism in order to be successful more

Partnering events for summer/fall 2010

Next up: BioPharm America 2010; BioPartnering Latin America 2010; BioBusiness Network 2010; BioNetwork West 2010; BioPartnering China 2010; EuroPLX 44 Barcelona; BIO-Europe 2010 more events

People on the move

Updated daily to provide the latest on career moves during summer 2010 career updates

The best of the web for dealmakers

The best partnering resources available online - from software tools to partnering quotes to reference library View resources